NEW YORK, March 7 – Sequenom has sold a MassArray system to genetic testing giant Quest Diagnostics, Sequenom said Wednesday.

Quest will use the MassArray system to identify disease-associated genetic variations and to determine susceptibility to hereditary conditions. The system has been installed at Nichols Institute, Quest's center for research and development, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.